Centers & Specialties

Cancer Center

Clinical Interests
  • Lung cancer
  • Small cell lung cancer
  • Neuroendocrine tumors
Medical Education
  • MD, PhD, Harvard Medical School
  • Residency, Brigham and Women's Hospital
  • Fellowship, Dana Farber Cancer Institute
Board Certifications
  • Internal Medicine
  • Medical Oncology
  • Boston: Massachusetts General Hospital
  • Waltham: Mass General Waltham
Insurances Accepted
  • Aetna Health Inc.
  • AllWays Health (NHP) - ACD
  • AllWays Health (NHP) - PBO
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna (PAL #'s)
  • Commonwealth Care Alliance
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Provider Gender


Anna F. Farago, MD, PhD, is an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital, an instructor at Harvard Medical School, and a research affiliate at the Koch Institute for Integrative Cancer Research at MIT. Dr. Farago cares for patients with lung cancer and other thoracic malignancies, and also performs clinical and translational research.

Dr. Farago's major research interests include studying small cell lung cancer (SCLC) and other lung neuroendocrine cancers. She works works with preclinical models including genetically engineered mouse models of SCLC in the laboratory of Dr. Tyler Jacks at MIT's Koch Institute for Integrative Cancer Research. She also works to develop new preclinical models of SCLC and performs research through clinical trials. Dr. Farago has been awarded several research grants, including grants from Uniting Against Lung Cancer and the Conquer Cancer Foundation of ASCO/AACR.


55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4000
Mass General Waltham
52 Second Avenue
Waltham, MA 02451
Phone: 781-487-6100
Fax: 617-487-6201